BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18956781)

  • 1. Optimization of the preparation of sonogenic phospholipids-based microbubbles by using central composite experimental design and response surface methodology.
    Zhao YZ; Lu CT; Mei XG
    Yao Xue Xue Bao; 2008 Aug; 43(8):862-7. PubMed ID: 18956781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S; Winter G; Coester C; Bekeredjian R
    J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimization of the preparation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine pharmacosomes using central composite design].
    Zhang ZR; Wang JX; Lu J
    Yao Xue Xue Bao; 2001 Jun; 36(6):456-61. PubMed ID: 12585133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
    Yang Y; Feng JF; Zhang H; Luo JY
    Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of contrast agents to ultrasound.
    Sboros V
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1117-36. PubMed ID: 18486270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of instantaneous uniformity of SonoVue microbubbles on binding characteristics of a new contrast agent targeted to choriocarcinoma cells in vitro].
    Zhou LX; Ding H; Jia CX; Li Y; Wei Q
    Ai Zheng; 2008 Jul; 27(7):692-7. PubMed ID: 18606060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
    Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
    J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbubbles as a novel contrast agent for brain MRI.
    Cheung JS; Chow AM; Guo H; Wu EX
    Neuroimage; 2009 Jul; 46(3):658-64. PubMed ID: 19269337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of sonoporation effect of liposomes and phospholipids-based microbubbles on cultured cell membrane].
    Zhao YZ; Luo YK; Tang J; Zhang Y; Lin Q; Mei XG
    Yao Xue Xue Bao; 2006 Dec; 41(12):1176-9. PubMed ID: 17290616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of size on the acoustic response of polymer-shelled contrast agents.
    Bloch SH; Short RE; Ferrara KW; Wisner ER
    Ultrasound Med Biol; 2005 Mar; 31(3):439-44. PubMed ID: 15749568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S; Ray S; Thakur RS
    Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The onset of microbubble vibration.
    Emmer M; van Wamel A; Goertz DE; de Jong N
    Ultrasound Med Biol; 2007 Jun; 33(6):941-9. PubMed ID: 17451868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery.
    Liu Y; Miyoshi H; Nakamura M
    J Control Release; 2006 Aug; 114(1):89-99. PubMed ID: 16824637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of ligustrazine phosphate thermosensitive gel formulation by central composite design-response surface methodology].
    Meng DM; Xu YH; Ding PT; Deng YJ; Wei MY
    Zhong Yao Cai; 2008 Feb; 31(2):286-8. PubMed ID: 18619280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the applications of ultrasonic microbubbles as gene delivery systems].
    Zhao YZ; Lu CT
    Yao Xue Xue Bao; 2007 Feb; 42(2):127-31. PubMed ID: 17518038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optima: a windows-based program for computer-aided optimization of controlled-release dosage forms.
    Lu DR; Abu-Izza K; Chen W
    Pharm Dev Technol; 1996 Dec; 1(4):405-14. PubMed ID: 9552324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Process optimization by response surface design and characterization study on geniposide pharmacosomes.
    Yue PF; Zheng Q; Wu B; Yang M; Wang MS; Zhang HY; Hu PY; Wu ZF
    Pharm Dev Technol; 2012; 17(1):94-102. PubMed ID: 20919929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding of targeted microbubble contrast agent to choriocarcinoma cells in vitro].
    Zhou LX; Zhu J; Ding H; Jia CX; Li Y; Wei Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1706-8. PubMed ID: 18024295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization and evaluation of a new antischistosomal drug QH917 self-microemulsifying drug delivery system].
    Zhang JY; Gan Y; Gan L; Zhu CL; Pan WS
    Yao Xue Xue Bao; 2007 Apr; 42(4):434-9. PubMed ID: 17633215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation and characterization of the puerarin submicron emulsion].
    Yue PF; Yuan HL; Yang M; You RH; Zhu WF; Xiao XH
    Yao Xue Xue Bao; 2007 Jun; 42(6):649-55. PubMed ID: 17702404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.